Navigation Links
Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp.

NEW YORK, March 4 /PRNewswire/ -- Crystal Research Associates, LLC announced today that it has issued an Executive Informational Overview(R) (EIO(R)) on Authentidate Holding Corp. (ADAT: Nasdaq). The full 56-page report can be found at

Authentidate Holding Corp. ("Authentidate(R)" or "the Company") is a worldwide provider of secure Health Information Exchange and workflow management software and services. The Company's software and web-based services enable healthcare organizations and other enterprises to increase revenues, improve productivity, and reduce costs by eliminating paper and manual work steps from clinical, administrative, and other processes, while enhancing compliance with regulatory requirements.

The web-based services are delivered as Software as a Service (SaaS) to customers. The Company develops offerings based on its Inscrybe(TM) platform, which integrates workflow automation, electronic signatures, transaction management capabilities, rules-based electronic forms, intelligent routing, and identity credentialing and verification. Inscrybe(TM) applications provide scalable solutions, facilitating a gradual migration from existing paper processes by offering customers the ability to choose the modules they want to implement and by supporting mixed-modal forms of communication (e.g., paper/fax and electronic).

The Company also incorporates content authentication into its products through its association with the U.S. Postal Service(R) (USPS(R)) and the use of the USPS(R) Electronic Postmark(R) (EPM(R)). The USPS(R) EPM(R) is a content integrity and time-and-date stamp application to verify the authenticity of an electronic document or file as of a specific point in time. Authentidate's primary initiative, Inscrybe(TM) Healthcare, is a secure workflow and information exchange network enabling healthcare industry participants to securely exchange and track documents, certificates, authorizations, and other information over different modes of communication. Inscrybe Healthcare facilitates order processing, online review, and electronic signature of healthcare documents, such as referrals, medical records, and support for insurance claims, while also validating the identity of the physician and other parties involved.

Authentidate's products and services further include both ExpressMD(TM) Solutions, a joint venture that provides remote, in-home monitoring systems for patients' vital signs and the delivery of results to their healthcare providers via the Internet, and Inscrybe(TM) Office. Authentidate is headquartered in Berkeley Heights, New Jersey, with offices in Dusseldorf, Germany, which are engaged in providing applications offering electronic signatures and timestamps for corporate and eHealth security solutions.

For more information, please visit the Company's corporate website at

About Crystal Research Associates, LLC

Crystal Research Associates, LLC is an independent research firm that provides institutional-quality, fee-based research to small and mid-cap companies. Crystal Research Associates' unique and novel product, the Executive Informational Overview(R) (EIO(R)), is free of investment ratings, target prices, and forward-looking financial models. The EIO(R) presents a crystal clear, detailed report on a company (public or private) in a manner that is easily understood by the Wall Street financial community. The EIO(R) details a company's product/technology/service offerings, market size(s), key intellectual property, leadership, growth strategy, competition, risks, financial statements, key events, and other such fundamental information. Crystal Research Associates has offices in New York City, Delray Beach, Montreal, and Toronto. Crystal Research Associates has been compensated by the Company in cash of thirty-eight thousand, five hundred U.S. dollars and one hundred and fifty thousand Warrants to purchase stock for its services in creating this report, for updates, and for printing costs.

Forward-Looking Safe Harbor Statement

Statements in this news release regarding future financial and operating results, potential applications of the Company's technology, opportunities for the Company, and any other statements about the future expectations, beliefs, goals, plans, or prospects expressed constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Any statements that are not statements of historical fact (including statements containing the words "will," "believes," "plans," "anticipates," "expects," "estimates," and similar expressions) should also be considered to be forward-looking statements. There are a number of important factors that could cause actual results or events to differ materially from those indicated by such forward-looking statements including, limited operating history, need for future capital, and economic conditions generally. Additional information on potential factors that could affect results and other risks and uncertainties are detailed from time to time in the Company's periodic reports, including forms filed with the SEC.

These statements, and other forward-looking statements, are not guarantees of future performance and involve risks and uncertainties. Crystal Research Associates assumes no obligation to update any of the forward-looking statements in this release.

SOURCE Crystal Research Associates, LLC
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. The New Crystalens HD Gives Many Baby Boomers and Seniors an Opportunity to See Clearly at All Distances while Reducing or Eliminating the Need for Glasses
2. Bausch & Lombs Crystalens to be Featured in Florida Advertising Campaign.
3. UCLA scientists develop crystal ball for personalized cancer treatment
4. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BELLUS Health Inc.
5. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Unilife Medical Solutions Limited
6. Crystallography reveals the 3-D structure of mammalian sperm receptor
7. Asia Wellness Cruise Offers Crystal Guests Peace of Mind, Body & Spirit
8. Crystalens HD(TM) Receives FDA Approval
9. Success for Crystal Meth Drug Addict on YouTube
10. Steve and Paula Mae Schwartz Honored With Publicity Club of New Englands Crystal Bell Award
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on BioCurex, Inc.
Post Your Comments:
(Date:6/27/2016)... ... June 27, 2016 , ... ... patient payment industry today announced its strategic partnership with Connance, a healthcare ... , The two companies’ proven, proprietary technology combine to provide health systems, ...
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. ... from injury. Recently, he has implemented orthobiologic procedures as a method for treating ... one of the first doctors to perform the treatment. Orthobiologics are substances that ...
(Date:6/24/2016)... , ... June 24, 2016 , ... June 19, 2016 ... dangers associated with chronic pain and the benefits of holistic treatments, Serenity Recovery ... are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Mass. , June 24, 2016   Pulmatrix, ... pharmaceutical company developing innovative inhaled drugs, announced today that ... Russell Investments reconstituted its comprehensive set of ... "This is an important milestone for Pulmatrix," ... will increase shareholder awareness of our progress in developing ...
(Date:6/23/2016)... HILLS, Calif. , June 23, 2016 Any ... the many challenges of the current process. Many of them ... because of the technical difficulties and high laboratory costs involved. ... have to offer it at such a high cost that ... afford it. Dr. Parsa Zadeh , founder ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
Breaking Medicine Technology: